Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis-Reference-Cited by-同舟云学术

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis

Published:2015-06-23 Issue:27 Volume:6 Page:23671-23687
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Duckworth Carrie A.¹,Guimond Scott E.²,Sindrewicz Paulina¹,Hughes Ashley J.²³,French Neil S.⁴,Lian Lu-Yun²,Yates Edwin A.²,Pritchard D. Mark¹,Rhodes Jonathan M.¹,Turnbull Jeremy E.²,Yu Lu-Gang¹

Affiliation:

1. Department of Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom

2. Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom

3. Diamond Light Source Ltd, Harwell Innovation Campus, Didcot, UK

4. Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-3 contributes to pathogenesis of IgA nephropathy;Kidney International;2024-07

2. Stachyose with effect on anti-angiogenic activity from Salvia yunnanensis;Journal of Functional Foods;2024-01

3. Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development;Cancers;2023-05-09

4. Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells;Cell Death & Disease;2023-04-13

5. Low sulfated heparan sulfate mimetic differentially affects repair in immune‐mediated and toxin‐induced experimental models of demyelination;Glia;2023-03-21